newsfilter
← Latest News
US Patent Applications (USPTO)·

New patent application published for: ENGINEERED HUMAN T CELLS COMPRISING A SWITCHABLE CHIMERIC ANTIGEN CELL SURFACE RECEPTOR AND METHODS FOR GENERATING THEM

The present invention relates to an engineered human T cell comprising a switchable chimeric antigen cell surface receptor, a pharmaceutical composition comprising the engineered human T cell, a kit comprising the engineered human T cell and a targeting module and a method for generating the engineered human T cell.

Company
AvenCell Therapeutics Inc.
Keywords
C12N5/0636, A61K40/11, A61K40/32, C07K14/7051, C07K14/70539, C12N9/226, C12N15/11, C12N15/88, C12N15/907